Literature DB >> 25071100

Optimal management of esophageal adenocarcinoma: should we be CROSS?

Elizabeth C Smyth1, Tom S Waddell2, David Cunningham2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25071100     DOI： 10.1200/JCO.2014.55.5243

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.

Authors:  Stefan Münch; Daniel Habermehl; Ayman Agha; Claus Belka; Stephanie E Combs; Renate Eckel; Helmut Friess; Alexander Gerbes; Natascha C Nüssler; Wolfgang Schepp; Roland M Schmid; Wolfgang Schmitt; Gabriele Schubert-Fritschle; Bernhard Weber; Jens Werner; Jutta Engel
Journal:  Strahlenther Onkol       Date:  2017-10-25       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.